Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vialsVabysmo has demonstrated rapid and robust vision and anatomical improvements in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO)The ready-to-use Vabysmo PFS is co-packaged with the only CE-marked needle specifically designed for intravitreal injection Basel, 13 December 2024– Roche (SIX: R ...

Laurentian Research is a resource industry veteran with a Ph.D. in geoscience and decades of investment experience. He leads the investing group The Natural Resources Hub, with an aim of helping membes uncover undervalued opportunities in the energy and mining sectors with multi-bagger potential. He is also passionate about helping members find dividend growth opportunities from long-term growth industries. Members get weekly newsletters, proprietary in-depth analyses, trade alerts, model portfolios, privat ...

- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts- Recommended Phase 2 dose (RP2D) of inupadenant 80mg + carboplatin/pemetrexed demonstrated 73.3% ORR, with 64.6% of patients achieving landmark 6-month PFS- Inupadenant + carboplatin/pemetrexed safety profile was manageable and tolerable, with no dose-dependent toxicity observed- Inupadenant deprioritized to focus resour ...

ENDEAVOUR ANNOUNCES POSITIVE PFS RESULTS FOR ASSAFOU PROJECT IN CÔTE D’IVOIRE $1,526m NPV(5%) and IRR of 28% at $2,000/oz • 329kozpa at AISC of $892/oz over first 10 years HIGHLIGHTS: PFS confirms Assafou's potential to become a tier 1 asset for EndeavourPFS highlights 329kozpa production at AISC of $892/oz over first 10 years: 15-year mine life based on maiden reserve of 4.1Moz Robust project economics with after-tax NPV(5%) of $1,526m and IRR of 28%, at a $2,000/oz gold priceInitial capital of $734m bas ...

ISELIN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Kim Strignile has joined the Human Resources team as Senior Vice President, HR Business Partner Director. Ms. Strignile will lead the bank’s HR Business Partner and Talent Acquisition teams, playing a pivotal role in driving its people strategy. In addition, Ms. Strignile will serve as a trusted advisor and change agent, collaborating closely with Provident’s leaders ...

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) -- -- Progressing through court-administered financial restructuring process with continued interest from multiple parties  EMERYVILLE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnolo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-31566 PROVIDENT FINANCIAL SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 42-1547151 (State or Other Ju ...

Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend ISELIN, NJ, October 29, 2024 - Provident Financial Services, Inc. (NYSE:PFS) (the "Company") reported net income of $46.4 million, or $0.36 per basic and diluted share for the three months ended September 30, 2024, compared to a net loss of $11.5 million, or $0.11 per basic and diluted share, for the three months ended June 30, 2024 and net income of $28.5 million, or $0.38 per basic and diluted share, for ...

Provident Financial Services, Inc. (NYSE:PFS) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Adriano Duarte – Investor Relations Officer Tony Labozzetta – President and Chief Executive Officer Tom Lyons – Senior Executive Vice President and Chief Financial Officer Conference Call Participants Greg Zingone – Piper Sandler Billy Young – RBC Capital Tim Switzer – KBW Manuel Navas – D.A. Davidson Operator Thank you for standing by. I would like to welcome everyone to the Prov ...

Provident Financial (PFS) reported $210.56 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 82.2%. EPS of $0.36 for the same period compares to $0.38 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $211.25 million, representing a surprise of -0.33%. The company delivered an EPS surprise of -21.74%, with the consensus EPS estimate being $0.46. While investors scrutinize revenue and earnings changes year-over-year and how they comp ...